Quantcast

AQT90 FLEX Opens Up for a New and Better Way of Measuring Troponin T at the Point of Care

September 20, 2010

COPENHAGEN, September 20, 2010 /PRNewswire/ — Radiometer has added the
cardiac marker Troponin T* (TnT) to its AQT90 FLEX immunoassay analyzer for
the use at the point of care. According to Radiometer President Peter
Kurstein
, the new marker enables healthcare professionals to improve
processes in emergency rooms and labs, ultimately helping hospitals improve
patient care and reduce costs.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100917/408671 )

Faster diagnosis and treatment

European Society of Cardiology and American College of Cardiology
guidelines point to troponin as the most definitive method of acute
myocardial infarction (AMI) detection. A turnaround time of less than 60
minutes is recommended for diagnosing AMI, which is often not matched by the
central lab.

On the AQT90 FLEX, TnT results are available at the point of care in just
12 minutes enabling caregivers to meet recommended guidelines. Because
testing is done directly on whole blood and is mostly automated, there is no
need for cartridge and sample preparation. “It’s the best of both worlds,”
Kurstein explains. “Clinicians have the results when and where they need
them, without having to wait for the lab or deal with the hassles of manual
testing.”

Compliance and lab control of point-of-care measurements

Compliance is key when providing test results at the point of care. With
a correlation of 0.999 to the Roche Elecsys 2010 troponin T 4th generation
assay and a correlation of 0.993 to the Roche Elecsys 2010 troponin T 5th
generation assay**, TnT measured on the AQT90 FLEX shows a performance
comparable to lab assays at the point of care. Automated QC system, user
lockout, and full integration to laboratory information systems keep the
process compliant and the lab in full control of point-of-care measurements.

Better care and reduced costs

By using the AQT90 FLEX, emergency departments can ensure a fast and
accurate process for ruling in/out AMI patients avoiding some of the
previously time consuming procedures. “This not only has the potential to
reduce overall costs, but also enables hospitals as a whole to better focus
their resources on the critically ill and on improving patient care,”
Kurstein concludes.

About the AQT90 FLEX

The AQT90 FLEX is currently the only platform available today to offer
both Troponin I and Troponin T at the point of care. In addition, the AQT90
FLEX also measures CKMB, Myoglobin, NT-proBNP, CRP, D-dimer and sshCG.

Go to http://www.aqt90flex.com

The AQT90 FLEX is not available for sale in the US.

About Radiometer

Radiometer is a world leader in the development, manufacturing and
distribution of technologically advanced acute care testing solutions.
Radiometer’s products and services simplify and automate all phases of acute
care testing, so hospitals can get fast results, reduce their workload and
the risk of errors, and improve cost effectiveness.

* Nonexclusive license granted under patent rights of Roche Diagnostics

** Ref: Viborg Hospital Correlation Study 2010

SOURCE Radiometer


Source: newswire



comments powered by Disqus